Results 1 to 10 of about 2,408 (165)

Deferred Cytoreductive Nephrectomy With Partial Hepatectomy for Giant Renal Cell Carcinoma of the Right Kidney With Extensive Hepatic Invasion: A Case Report in the Era of Systemic Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors [PDF]

IJU Case Reports
Introduction Deferred cytoreductive nephrectomy may improve the prognosis of patients with metastatic renal cell carcinoma (RCC). However, reports of combined hepatic resection for RCC with liver invasion are limited, and treatment strategies remain ...
Yuki Hiroshi, Takamitsu Inoue, Takuya Minagawa, Masaki Takahashi, Akinobu Katami, Mizuki Onozawa, Masahiro Shinoda, Osamu Itano, Jun Miyazaki   +8 more
doaj   +3 more sources

Cytoreductive Nephrectomy and Nephrectomy/Complete Metastasectomy for Metastatic Renal Cancer [PDF]

Scientific World Journal, The, 2007
The objective of this study was to determine our institutional experience with cytoreductive nephrectomy alone or in conjunction with nephrectomy complete metastasectomy.
Robert Motzer, Paul Russo, Andrew Vickers   +2 more
exaly   +5 more sources

Cytoreductive Nephrectomy in 2021: Obsolete [PDF]

European Urology Open Science, 2022
Luis Meza, Neal S. Chawla, Gianluca Giannarini, Sumanta K. Pal   +3 more
doaj   +4 more sources

Outcome benefits of upfront cytoreductive nephrectomy for patients with metastatic renal cell carcinoma: An analysis of the TriNetX database. [PDF]

PLoS ONE
BackgroundThe role of upfront cytoreductive nephrectomy remains debatable in the present era of tyrosine kinase inhibitors and immune checkpoint inhibitors.
Gu-Shun Lai, Jian-Ri Li, Shian-Shiang Wang, Chuan-Shu Chen, Chun-Kuang Yang, Chia-Yen Lin, Sheng-Chun Hung, Kun-Yuan Chiu, Shun-Fa Yang   +8 more
doaj   +2 more sources

Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial [PDF]

BMC Cancer
Background Primary tumor removal by cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma patients has been investigated in the context of various treatment regimens. Two randomized controlled trials investigated the role and timing of
Laura Iisager, Johanne Ahrenfeldt, Frede Donskov, Börje Ljungberg, Axel Bex, Lars Lund, Iben Lyskjær, Niels Fristrup   +7 more
doaj   +2 more sources

The Evolving Landscape of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma [PDF]

Cancers, 2023
Vladimír Študent, Bohuslav Melichar, Hana Študentová   +2 more
exaly   +2 more sources

Cytoreductive Nephrectomy Following Immunotherapy-Base Treatment in Metastatic Renal Cell Carcinoma: A Case Series and Review of Current Literature

Current Oncology, 2021
The role and timing of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma receiving immunotherapy-based regimens is unclear. However, the ability to achieve a complete response for metastatic renal cell carcinoma likely requires a
Scott J. Dawsey, Steven C. Campbell, Moshe C. Ornstein   +2 more
doaj   +1 more source

Deliberation on Deferred Cytoreductive Nephrectomy and Postoperative Treatment for Advanced Renal Cell Carcinoma: A Case Report

Case Reports in Oncology, 2022
In a rare case, free from systemic therapy, deferred cytoreductive nephrectomy was implemented in treating an advanced renal cell carcinoma with liver, lung, and splenic colon metastases.
Takuya Nakagawa, Yoshihide Kawasaki, Satoko Sato, Hiromichi Katayama, Yohei Satake, Shuichi Shimada, Takuma Sato, Naoki Kawamorita, Shinichi Yamashita, Koji Mitsuzuka, Atsushi Kohyama, Masaharu Ishida, Hideo Ohtsuka, Michiaki Unno, Akihiro Ito   +14 more
doaj   +1 more source

The Role of Cytoreductive Nephrectomy in Renal Cell Carcinoma with Sarcomatoid Histology: A Case Series and Review of the Literature

Current Oncology, 2022
Background: Renal cell carcinoma with sarcomatoid dedifferentiation represents a rare histological entity characterized by aggressive behavior, limited efficacy of tyrosine kinase inhibitors or mTOR inhibitors, and poor outcome.
Hana Studentova, Nikol Rusarova, Andrea Ondruskova, Anezka Zemankova, Vladimir Student, Daniela Skanderova, Bohuslav Melichar   +6 more
doaj   +1 more source

Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah’s witness: A case report

Frontiers in Oncology, 2022
The role of cytoreductive nephrectomy in patients with metastatic renal cell carcinoma is a subject of debate. We report a durable complete response in a 62-year-old man Jehovah’s Witness with metastatic clear cell renal cell carcinoma who received two ...
Tony Zibo Zhuang, Lara Harik, Lara Harik, Seth Force, Seth Force, Agreen Hadadi, Mehmet Asim Bilen, Mehmet Asim Bilen, Jacqueline T. Brown, Jacqueline T. Brown, Bradley C. Carthon, Bradley C. Carthon, Jamie Goldman, Jamie Goldman, Omer Kucuk, Omer Kucuk, Viraj A. Master, Viraj A. Master, Bassel Nazha, Bassel Nazha   +19 more
doaj   +1 more source